Immune related response criteria
Showing 1 - 25 of >10,000
Pregnancy Related Trial (Sangobion and Thiamine Hydrochloride, Sangobion, Thiamine HCl and Vitamin B12)
Recruiting
- Pregnancy Related
- Sangobion and Thiamine Hydrochloride
- Sangobion, Thiamine hydrochloride and Vitamin B12
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- Recombinant protein vaccine and adenovirus vector vaccine
- (no location specified)
Feb 12, 2023
Vaccine Response Impaired Trial in Irvine, Charlestown (low power laser)
Completed
- Vaccine Response Impaired
- low power laser
-
Irvine, California
- +1 more
Oct 28, 2022
Inflammatory Response, Metabolic Disturbance, Immune Suppression Trial in Kannapolis (Cranberry Juice, Placebo)
Completed
- Inflammatory Response
- +2 more
- Cranberry Juice
- Placebo
-
Kannapolis, North CarolinaAppalachian State University Human Performance Lab, North Caroli
Jan 24, 2023
Immun Response in Children With MIS-C
Not yet recruiting
- MIS-C Multisystem Inflammatory Syndrome in Children
- Analysis of cytokines and immun cell related markers
-
Cologne, GermanyUniversity of Cologne, Medical Faculty
Sep 13, 2021
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
COVID-19 Vaccines in Cancer, Transplant or Cellular Therapy
Recruiting
- Cancer
- +7 more
-
Memphis, Tennessee
- +2 more
Mar 2, 2022
Respiratory System Abnormalities Trial in Al-Kharj (Manual Diaphragm Release, control group)
Completed
- Respiratory System Abnormalities
- Manual Diaphragm Release
- control group
-
Al-Kharj, Riyadh, Saudi ArabiaOutpatient Clinic of College of Applied Medical Sciences, Prince
Mar 27, 2023
Base on Single Cell Multi-Omics
Recruiting
- Immune System and Related Disorders
- Recently Vaccination
-
Shanghai, ChinaCardiology, Ren Ji Hospital
May 29, 2021
Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4
Terminated
- Unresectable or Metastatic Melanoma
- Ipilimumab
- +3 more
-
New York, New York
- +4 more
Oct 3, 2022
NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor Trial in Boulogne
Recruiting
- NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor
- assessment of the predictive value of ctDNA level of the prominent mutant allele variation between baseline and week 6, on response to treatment according to RECIST 1.1 criteria.
-
Boulogne Billancourt, France
- +2 more
Jul 12, 2021
Professional's Health in Epidemiological Crisis Covid-19
Recruiting
- COVID-19
- SARS-CoV-2
- Immune response monitoring , blood samples
-
Mataró, Barcelona, SpainJordi Gol i Gurina Foundation
May 18, 2021
Solid Tumor, Adult Trial in Albury (Tiragolumab, Atezolizumab)
Not yet recruiting
- Solid Tumor, Adult
- Tiragolumab
- Atezolizumab
-
Albury, New South Wales, Australia
- +1 more
Aug 22, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Itacitinib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 20, 2022
Colorectal Cancer, Pancreas Tumor, Biliary Tract Tumor Trial (Tumor samples)
Not yet recruiting
- Colorectal Cancer
- +3 more
- Tumor samples
- (no location specified)
Jan 12, 2021
Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)
Not yet recruiting
- Clear-cell Metastatic Renal Cell Carcinoma
- Drug: Pembrolizumab
-
Guangzhou, Guangdong, China
- +1 more
Oct 7, 2022
Periodontal Diseases, Periodontitis Trial in Alcorcon (Crevicular fluid analysis by using ELISA testing.)
Not yet recruiting
- Periodontal Diseases
- Periodontitis
- Crevicular fluid analysis by using ELISA testing.
-
Alcorcon, Madrid, SpainClinica Universitaria Universidad Rey Juan Carlos
Apr 26, 2021
Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)
Recruiting
- Cancer Patients
- Low-dose radiotherapy combined with conventional fractionated radiotherapy
-
Jinan, In Shandong Province, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Sepsis Trial in Seoul (Prognostic factor)
Recruiting
- Sepsis
- Prognostic factor
-
Seoul, Korea, Republic ofKangdonSHH
Jun 20, 2023
Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)
Not yet recruiting
- Recurrent Glioblastoma
- Activated T cells
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Apr 21, 2022
Tumor and Peripheral Blood to Evaluate Efficacy of Cancer
Recruiting
- Lung Cancer
- Esophageal Cancer
- In vitro stimulation of Pbmc with tumor antigen nanoparticles
-
Suzhou, Jiangsu, ChinaThe first affiliated hospital of soochow university
Mar 16, 2023
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Tirelizumab
- +3 more
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai jiaotong university school of medicine
Nov 6, 2023